MENU

FTH

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Faeth Therapeutics (FTH) Ownership - Who owns Faeth Therapeutics?

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

702.21M

P/E Ratio

N/A

Total Cash

N/A

Projected Growth

N/A

Total Debt

N/A

Revenue

N/A

Risk (Beta)

-0.87

Dividend Yield

N/A

Total Cash/Share

N/A

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

FTH

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for FTH

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details